Outlook Therapeutics Inc (OTLK) 재무 분석
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|---|
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Cost Of Revenue | 88.64%0.02 | 0.15 | 0.03 | 0.92 | 0.44 |
| Gross Profit | 62.24%-0.01 | -0.02 | -1.24 | -1.01 | 1.07 |
20.56%7.55 | 9.50 | - | - | - | |
| Selling, General, and Administrative | 20.56%7.55 | 9.50 | - | - | - |
| Research and Development | 27.76%3.25 | 4.50 | - | - | - |
| Depreciation and Amortization | 54.66%0.01 | 0.03 | 0.03 | 0.03 | 0.03 |
| Operating Income/Loss | 22.93%-10.81 | -14.03 | -13.48 | -17.31 | -15.75 |
| Net Interest Income/Expense | 133.33%0.00 | 0.00 | - | -0.26 | -0.05 |
| Income/Loss From Equity Method Investments | 9.10%-0.04 | -0.05 | -0.04 | -0.04 | -0.03 |
| Income/Loss From Continuing Operations Before Tax | 356.30%-20.32 | -4.45 | -23.06 | -14.85 | -20.15 |
356.30%-20.32 | -4.45 | -23.06 | -13.29 | -20.15 | |
| Attributable To Parent | 356.30%-20.32 | -4.45 | -23.06 | -13.29 | -20.15 |
| Available To Common Stockholders, Basic | 356.30%-20.32 | -4.45 | -23.06 | -13.29 | -20.15 |
| Basic Average Shares | 67.09%136.74 | 81.84 | 60.21 | 4.13 | 36.96 |
| Diluted Average Shares | 67.09%136.74 | 81.84 | 60.21 | 4.13 | 36.96 |
| Basic Earnings Per Share | 200.00%-0.15 | -0.05 | -0.38 | -0.19 | -0.55 |
| Diluted Earnings Per Share | 200.00%-0.15 | -0.05 | -0.38 | -0.19 | -0.55 |